Liberty Health Sciences Strengthens Presence in Florida with St. Petersburg Cannabis Education Center

Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

  • Liberty’s second CEC opened its doors in April in St. Petersburg
  • Site for Tampa CEC announced as Liberty continues Florida expansion

TORONTO, May 10, 2018 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) (“Liberty” or the “Company”) today announced the successful opening of its second Florida Cannabis Education Center (“CEC”) with a grand opening ceremony set for May 17, 2018 at 5:30 pm EST. The St. Petersburg location is strategically located within a five-mile radius of 90 percent of the city’s 257,000 residents.

Liberty Health Sciences is proud to be part of the St. Petersburg community and to fulfill our promise to provide the area with our patient-centric approach to cannabis through unparalleled service and educational resources. Liberty brings an unwavering commitment to providing patients in need with access to high-quality pharmaceutical-grade cannabis.

George Scorsis, Director and CEO of Liberty

Our newest Cannabis Education Center, combined with the company’s recently announced delivery hub, will allow us to efficiently serve the greater St. Petersburg area and reach more and more patients from across the state. Liberty will continue to execute on our aggressive growth plan as we bring CEC’s to even more locations in Florida to serve the expanding patient community.

Conveniently located at the intersection of St. Petersburg’s rapidly growing Historic and Edge Districts, and in close proximity to St. Petersburg General Hospital, Liberty’s newest CEC is ideally situated to serve the surrounding areas and establish relationships with the nearby medical community.

The Company also shared that its previously announced CEC in Tampa is scheduled to open on May 18, 2018. The Tampa CEC will be conveniently located within a private hospital that sees approximately 15,000 patients a week.

Liberty’s Cannabis Education Centers offer patients access to high quality, clean and safe pharmaceutical grade cannabis. Each location provides exceptional patient care through a comprehensive educational platform which includes tools, resources and compassionate one-on-one consultations geared towards educating patients on cannabis use as a safe alternative in treating symptoms.

All Liberty’s CEC locations in Florida will offer a wide variety of products and brands such as Aphria, Mary’s Medicinals and Incredibles edibles, providing patients in need with a variety of options to meet their needs across all state-approved methods of cannabis consumption including vapes, oils, tinctures and capsules.

Liberty’s dispensary operations and plans are subject to final approval from the Florida Department of Health’s Office of Medical Marijuana Use.

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

For more information, please visit libertyhealthsciences.com.

Original press release

The most reliable, fact-based information on Liberty Health Sciences found only on its Investor Dashboard.

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.

Get Our Sunday Newsletter